Alzchem Group AG (FRA:ACT) Issuance of Debt: €0.0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:ACT Alzchem Group AG FRA:ACT
67 GF Score
Price €171.90
GF Value €58.91
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Alzchem Group AG Issuance of Debt?

Alzchem Group AG FRA:ACT +1.00% 67 Issuance of Debt is €0.0 Mil as of Mar. 2026. GuruFocus rates FRA:ACT with a GF Score™ of 67/100 and a GF Value™ of €58.91 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Alzchem Group AG's Issuance of Debt for the three months ended in Mar. 2026 was €0.0 Mil.

Alzchem Group AG's Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2026 was €0.0 Mil.

Alzchem Group AG Issuance of Debt Related Terms

Alzchem Group AG Issuance of Debt Historical Data

* Premium members only.

The historical data trend for Alzchem Group AG's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alzchem Group AG Issuance of Debt Chart

Alzchem Group AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 56.35 30.00 0.00 0.00

Alzchem Group AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:ACT
67GF Score
Alzchem Group AG FRA:ACT
Issuance of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alzchem Group AG Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Issuance of Debt →
What does a Issuance of Debt of €0.0 Mil mean?
Alzchem Group AG (FRA:ACT) has a Issuance of Debt of €0.0 Mil as of Mar. 2026. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Alzchem Group AG and its competitors.
Is Alzchem Group AG's Issuance of Debt too high?
Alzchem Group AG's current Issuance of Debt is €0.0 Mil. Overall, Alzchem Group AG has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Alzchem Group AG's Issuance of Debt compare to LIN and SHW?
Alzchem Group AG's Issuance of Debt of €0.0 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Issuance of Debt for a Chemicals company?
A good Issuance of Debt depends on the Chemicals industry context. However, Issuance of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Issuance of Debt mean?
A high Issuance of Debt can signal that a stock is expensive relative to its fundamentals. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Alzchem Group AG and its competitors. Alzchem Group AG's current Issuance of Debt is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alzchem Group AG stock overvalued right now?
Based on GuruFocus' analysis, Alzchem Group AG (FRA:ACT) is currently considered Significantly Overvalued. The stock's GF Value™ is €58.91, compared to a current price of €171.90 — trading 191.8% above its estimated fair value. The current Issuance of Debt is €0.0 Mil. Alzchem Group AG's overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Issuance of Debt calculated?
Issuance of Debt is calculated from a company's financial statements. For Alzchem Group AG (FRA:ACT), the current Issuance of Debt is €0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alzchem Group AG (FRA:ACT) Overvalued in 2026?

Based on GuruFocus' analysis, Alzchem Group AG stock appears to be overvalued. The current stock price of €171.90 is trading 191.8% above its estimated GF Value™ of €58.91. GuruFocus considers Alzchem Group AG to be Significantly Overvalued.

Key valuation signals for FRA:ACT:

  • Issuance of Debt: €0.0 Mil
  • GF Value™: €58.91 vs. price of €171.90 (191.8% above fair value)
  • GF Score™: 67/100 with 4 warning signs

No single metric tells the full story. See the FRA:ACT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alzchem Group AG Business Description

Address Dr.-Albert-Frank-Street 32, Trostberg, DEU, 83308
Alzchem Group AG is an international chemical company. The reportable segments of the company are Specialty Chemicals, Basics and Intermediates, and Other Holdings. The specialty chemicals segment focuses on the production and distribution of high-quality growth products, and the basics and intermediates segment covers the production of basic and intermediate products. It generates a majority of its revenue from the Specialty Chemical segment. Geographically it serves Europe, Asia, and the Rest of the world whilst deriving substantial revenue from European Union.
67GF Score

Get the complete analysis for FRA:ACT

Issuance of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€171.90
Price
€58.91
GF Value